Table 3

Comparison of IN-HOSPITAL primary and secondary outcomes by treatment group (N=668)

OutcomesUsual care (n=330)Missing, n (%)CPAP (n=338)Missing, n (%)% difference (95% CI)Median difference (95% CI)P value*
A. ED outcome
 ED disposition, n (%)000.19
  Admitted to study hospital307 (93.0)317 (93.8)
  Discharged home16 (4.8)12 (3.6)
  Transferred to private hospital3 (0.9)8 (2.4)
  Died in ED4 (1.2)1 (0.3)
 ED discharge diagnosis0
  APO89 (27.1)1 (0.3)102 (30.2)3.1 (−3.8 to 10.0)0.37
  COPD185 (56.2)1 (0.3)200 (59.2)3.0 (−4.5 to 10.5)0.44
  Pneumonia74 (22.5)1 (0.3)61 (18.0)−4.5 (−10.6 to 1.6)0.15
  Asthma16 (4.9)1 (0.3)11 (3.3)−1.6 (−4.6 to 1.4)0.29
  AMI19 (5.8)1 (0.3)28 (8.3)2.5 (−1.4 to 6.4)0.21
  Heart failure44 (13.4)1 (0.3)49 (14.5)1.1 (−4.2 to 6.4)0.68
  Sepsis8 (2.4)1 (0.3)9 (2.7)0.3 (−2.1 to 2.7)0.85
 ED interventions
 CPAP commenced in ED47 (14.2)0NANANA
 BiPAP commenced in ED106 (32.1)0135 (39.9)07.8 (0.5 to 15.1)0.04
 Intubation in ED, n (%)15 (4.5)07 (2.1)0−2.4 (−5.1 to 0.3)0.07
B. In-hospital outcomes Usual care (n=307) CPAP (n=317)
 Primary outcome
  Hospital length of stay (hours), median (IQR)100.6 (50.7 to 187.5)0114.2 (59.3 to 188.6)08.6 (−4.0 to 21.6)0.18
  Hospital length of stay (days), median (IQR)4.2 (2.1 to 7.8)4.8 (2.5 to 7.9)0.36 (−0.17 to 0.90)0.18
 Secondary outcomes
  ICU admission50 (16.3)046 (14.5)0−1.8 (−7.5 to 3.9)0.54
  Survival, n (%)
   Survived to hospital discharge274 (89.3)282 (89.0)−0.3 (−5.2 to 4.6)0.91
   Death within 30 days43 (14.0)51 (16.1)2.1 (−3.5 to 7.7)0.47
  • *Mann-Whitney test for continuous variables, and Pearson’s χ2 test for categorical variables.

  • AMI, acute myocardial infarction; BiPAP, bilevel positive airway pressure; COPD, chronic obstructive pulmonary disease; CPAP, continuous positive airway pressure; ICU, intensive care unit.;